AZN
NASDAQ
GB
AstraZeneca PLC - American Depositary Shares
$203,49
▲ +$2,76
(+1,38%)
Vol 2.0M
11
Skor Kualitas
ok
Pemeriksaan Mendalam
2/5
ok
Pendapatan ✓
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$213.8B
P/E
30,6
ROE
21,8%
Margin
16,2%
D/E
71,11
Beta
0,86
Imbal Hasil Dividen
1,77%
52W
$9574–$14206
Konsensus Wall Street
36 analis · Apr 202612
Beli Kuat
17
Beli
5
Tahan
2
Jual
0
Jual Kuat
80,6%
Peringkat Beli
Grafik Harga
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $2,15 | $2,12 | $-0,03 |
| Sep 2025 | $2,35 | $2,38 | +$0,03 |
| Jun 2025 | $2,35 | $2,17 | $-0,18 |
| Mar 2025 | $2,28 | $2,49 | +$0,21 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $14.9B | $13.6B | $14.5B | $15.2B | $15.5B |
| Laba Bersih | — | $1.5B | $2.9B | $2.5B | $2.5B | $2.3B |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 19.8% | 19.8% | 19.8% | 19.8% | 21.8% | 21.8% |
| P/E (TTM) | 25.45 | 29.72 | 28.13 | 30.84 | 30.10 | 30.65 |
| Net Margin | 17.0% | 14.7% | 14.7% | 14.7% | 16.2% | 16.2% |
| Gross Margin | 82.0% | 82.1% | 82.1% | 82.1% | 81.9% | 81.9% |
| D/E Ratio | 73.43 | 73.43 | 73.43 | 73.43 | 71.11 | 71.11 |
| Current Ratio | 0.86 | 0.86 | 0.86 | 0.86 | 0.88 | 0.88 |
Rasio Utama
ROA (TTM)
8,6%
P/S (TTM)
4,96
P/B
5,4
EPS (TTM)
$6,02
CF/Share
$5,82
Pertumbuhan Pendapatan 3T
+13,1%
52W High
$14206,00
52W Low
$9573,51
$9573,51
Rentang 52 Minggu
$14206,00
Kesehatan Keuangan
Arus Kas Bebas
$1.1B
Utang Bersih
$23.9B
Kas
$5.7B
Total Utang
$29.6B
Per tanggal Des 31, 2025
Як AZN виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Large-cap Pharmaceuticals ($10B+) · 7 компаній
Оцінка AZN vs аналоги Pharmaceuticals
P/E
30,7
▲
68%
di atas
rekan
(18,2)
vs Rekan
vs Industri
Lebih mahal
P/S
5,0
▲
57%
di atas
rekan
(3,2)
vs Rekan
vs Industri
Overvalued
P/B
5,4
▲
169%
di atas
rekan
(2,0)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
1,8%
▼
42%
di bawah
rekan
(3,1%)
vs Rekan
vs Industri
Yield rendah
Прибутковість AZN vs аналоги Pharmaceuticals
ROE
21,8%
▲
88%
di atas
rekan
(11,6%)
vs Rekan
vs Industri
Tingkat atas
Net margin
16,2%
▼
12%
di bawah
rekan
(18,4%)
vs Rekan
vs Industri
Lemah
Валова маржа
81,9%
▲
13%
di atas
rekan
(72,3%)
vs Rekan
vs Industri
Sejajar
ROA
8,6%
▲
107%
di atas
rekan
(4,2%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя AZN vs аналоги Pharmaceuticals
D/E ratio
71,1
▲
0%
di atas
rekan
(71,1)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
0,9
▼
47%
di bawah
rekan
(1,7)
vs Rekan
vs Industri
Likuiditas rendah
Beta
0,9
▲
0%
di atas
rekan
(0,9)
vs Rekan
vs Industri
Kurang volatil
Радар фундаменталів AZN
AZN
Median rekan
Industri
AZN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
AZN vs аналоги: ключові метрики
Dividen
$6,28
/ tahun
Feb 19, 2026
$2,1530
Agu 08, 2025
$1,0300
Feb 21, 2025
$2,1000
Agu 09, 2024
$1,0000
Feb 22, 2024
$1,9700
Agu 10, 2023
$0,9300
Feb 23, 2023
$1,9700
Agu 11, 2022
$0,9300